Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (91-100 of 466) with videos related to

Pageof 47
Sort By:
AIDS (London, England)|September 12, 2008
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysisHla-Hla Thein, Qilong Yi, Gregory J Dore, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2018
Management of acute HCV infection in the era of direct-acting antiviral therapyMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
The International Journal on Drug Policy|September 15, 2007
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC studyOanh K Nguyen, Gregory J Dore, John M Kaldor, et al.
Journal of Gastroenterology and Hepatology|January 30, 2009
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, AustraliaVan T T Nguyen, Janaki Amin, Matthew G Law, et al.
AIDS (London, England)|September 22, 2007
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et alGail V Matthews, Margaret Hellard, John Kaldor, et al.
Addiction (Abingdon, England)|October 2, 2020
The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison settingLise Lafferty, Jake Rance, Gregory J Dore, et al.
The International Journal on Drug Policy|June 11, 2024
Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage StudyAlison D Marshall, Jake Rance, Gregory J Dore, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Hepatology Communications|March 30, 2023
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021Joanne Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Contemporary Clinical Trials|April 21, 2009
Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyAnna Doab, Libby Topp, Carolyn A Day, et al.
Pageof 47

Showing results (91-100 of 466) with videos related to

Sort By:
Pageof 47
AIDS (London, England)|September 12, 2008
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysisHla-Hla Thein, Qilong Yi, Gregory J Dore, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2018
Management of acute HCV infection in the era of direct-acting antiviral therapyMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
The International Journal on Drug Policy|September 15, 2007
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC studyOanh K Nguyen, Gregory J Dore, John M Kaldor, et al.
Journal of Gastroenterology and Hepatology|January 30, 2009
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, AustraliaVan T T Nguyen, Janaki Amin, Matthew G Law, et al.
AIDS (London, England)|September 22, 2007
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et alGail V Matthews, Margaret Hellard, John Kaldor, et al.
Addiction (Abingdon, England)|October 2, 2020
The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison settingLise Lafferty, Jake Rance, Gregory J Dore, et al.
The International Journal on Drug Policy|June 11, 2024
Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage StudyAlison D Marshall, Jake Rance, Gregory J Dore, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Hepatology Communications|March 30, 2023
Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021Joanne Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Contemporary Clinical Trials|April 21, 2009
Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyAnna Doab, Libby Topp, Carolyn A Day, et al.
Pageof 47